coronavirus

July 22, 2020

Study to explore how COVID affects cognition over time

The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD).

By Nancy Humphrey
July 22, 2020

New data offer insights on COVID treatments for people with cancer

Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.

By Tom Wilemon
July 16, 2020

Button Project lets children see the faces behind the masks

Children and their families who come to Monroe Carell Jr. Children’s Hospital at Vanderbilt for their care are used to seeing the friendly faces and smiles of staff, nurses and doctors.

By Christina Echegaray
July 16, 2020

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.

By VUMC News and Communications
July 15, 2020

Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.

By Bill Snyder
July 15, 2020

Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

By Bill Snyder
July 14, 2020

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
By Leigh MacMillan
July 10, 2020

VUMC team fills COVID information gaps for web users

For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.
By Paul Govern
July 9, 2020

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.
By VUMC News and Communications
July 9, 2020

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.
By Bill Snyder
July 9, 2020

Coordinated care network ensures COVID-positive patient makes recovery

On March 27, Nashville resident Bill Boyce, 73, earned the unwelcome distinction of becoming the first patient intubated on Vanderbilt University Medical Center’s dedicated COVID-19 unit.
By Jill Clendening
July 8, 2020

Clothes Closet in need of donations of new items

Due to COVID-19, used items are no longer accepted, but the need to help patients continues
By Wayne Wood
July 2, 2020

Fe y Salud webinar addresses disproportionate effects of COVID-19 on Latino community

The Latino community is affected disproportionately by COVID-19. News outlets report leaders and lawmakers calling its impact “catastrophic.” In the state of Tennessee, one-third of residents who test positive for the coronavirus are Hispanic, even though only 5.6 percent of the population is Hispanic.
By Matt Schorr
1 … 8 9 10 11 12 … 23